Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future

Off-Target Gene Regulation Mediated by Transcriptional Repressors of Antimicrobial Efflux Pump Genes in Neisseria gonorrhoeae

(2011) Paul J. T. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

(2011) Makoto Ohnishi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Taking the Gonococcus-Human Relationship to a Whole New Level: Implications for the Coevolution of Microbes and Humans

(2011) W. M. Shafer et al.   mBio

Opportunity and Means: Horizontal Gene Transfer from the Human Host to a Bacterial Pathogen

(2011) M. T. Anderson et al.   mBio

Gonococcal Resistance: Are Cephalosporins Next?

(2011) Robert D. Kirkcaldy et al.   Current Infectious Disease Reports

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

(2010) Robert Bucki et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins inNeisseria gonorrhoeae: Role of Epistatic Mutations

(2010) Joshua Tomberg et al.   BIOCHEMISTRY

Species-Specific and Inhibitor-Dependent Conformations of LpxC: Implications for Antibiotic Design

(2010) Chul-Jin Lee et al.   CHEMISTRY & BIOLOGY

Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains

(2010) D. M. Whiley et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone

(2010) S.-G. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe

(2010) S. A. Chisholm et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?

(2010) S. A. Chisholm et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden

(2010) D. Golparian et al.   SEXUALLY TRANSMITTED INFECTIONS

The Gonococcus fights back: is this time a knock out?

(2010) D. A. Lewis   SEXUALLY TRANSMITTED INFECTIONS

Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae

(2009) S. Zhao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mosaic Penicillin-Binding Protein 2 in Neisseria gonorrhoeae Isolates Collected in 2008 in San Francisco, California

(2009) M. Pandori et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The use of cephalosporins for gonorrhea: the impending problem of resistance

(2009) Pennan M Barry et al.   EXPERT OPINION ON PHARMACOTHERAPY

Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeae

(2009) John W Tapsall et al.   Expert Review of Anti-Infective Therapy

Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes

(2009) M. Unemo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinically relevant mutations that cause derepression of theNeisseria gonorrhoeaeMtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance andin vivofitness

(2008) Douglas M. Warner et al.   MOLECULAR MICROBIOLOGY